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Abstract
Immunopathological events are key for the development of enzootic pneumonia (EP), which is
macroscopically observed as cranioventral pulmonary consolidation (CVPC). This study aimed
to investigate the putative association between the humoral immune response against Myco-
plasma hyopneumoniae (M. hyopneumoniae) and prevalence and extension of CVPC in 1)
experimentally infected pigs, 2) slaughtered pigs and 3) sequentially necropsied pigs in a longi-
tudinal study. CVPC was scored by means of the European Pharmacopoeia recommended
methodology. Specific IgG, IgG1 and IgG2 antibodies were assessed in serum. In addition,
mucosal IgG and IgA antibodies were analyzed in broncho-alveolar lavage fluid (BALF) from
experimentally challenged pigs. The systemic humoral immune response in experimentally
infected pigs was delayed in onset whereas humoral respiratory mucosal immune response
appeared more rapidly but declined earlier. Although low, BALF IgG antibodies showed the
highest correlation with CVPC scores (r = 0.49, p<0.05). In slaughter-aged pigs, both percent-
age of lungs with CVPC and mean lung lesion score were significantly higher in M. hyopneumo-
niae seropositive farms compared to the seronegative ones (p<0.001). Similarly, seropositive
sequentially necropsied pigs showed more severe CVPC than seronegative ones. Overall,
mean serological values might help to forecast prevalence and severity of EP-like lung lesions
using a population based approach. Remarkably, the specific systemic humoral immune
response was found to be predominated by the IgG2 subclass, suggesting a dominant Th1-
mediated immune response to M. hyopneumoniae.
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Introduction
One of the main pulmonary lesions found in pigs on abattoir inspection is cranioventral pul-
monary consolidation (CVPC) [1, 2]. Mycoplasma hyopneumoniae (M. hyopneumoniae) is
considered the most important primary bacterial respiratory pathogen involved in such lung
lesions. When secondary or concomitant infections by other respiratory bacterial organisms
are also implicated, enzootic pneumonia (EP) occurs [3].
CVPC quantification by means of lung lesion scoring is frequently used to estimate the inci-
dence and severity of lung lesions associated to M. hyopneumoniae infections, at experimental,
herd and abattoir levels [4–6]. Nevertheless, post-mortem lung evaluation is an end-point
parameter that does not provide information on the ongoing respiratory problems in any of the
cases [6]. Thus, it would be of general interest to find an ante-mortem parameter that would
provide reliable and real-time information in relation with CVPC prevalence and severity.
Immunopathological events are considered to play an important role in both M. hyopneu-
moniae infection pattern and development of the associated lung lesions [3]. In connection
with this matter, relationship between presence of M. hyopneumoniae antibodies and CVPC
development has been analyzed in several studies. However, while some studies found a signif-
icant positive correlation between both parameters [2, 7–10], others did not find such associa-
tion [1, 11]. Noteworthy, such relationship has been assessed at a population-based level and
scarce information is available at individual level [10]. Hence, the relationship between anti-
body levels against M. hyopneumoniae as a tool to assess lung lesions deserves further investi-
gation. On the other hand, most of the commercially available enzyme-linked immunosorbent
assay (ELISA) kits are designed to detect specific M. hyopneumoniae IgG antibodies in serum,
but information on other humoral immune parameters and their relationship with CVPC is
not available. Therefore, the present study sought to investigate the potential association
between different humoral immune parameters, both at local and systemic levels, with the
prevalence and severity of CVPC in pigs naturally and experimentally infected with M.
hyopneumoniae.
Materials and methods
Study design
In order to accomplish the abovementioned objective, samples from three different published
studies were used: 1) samples from M. hyopneumoniae experimentally inoculated animals [4];
2) samples from slaughtered pigs coming from different farms [2] and 3) samples from non-
vaccinated pigs belonging to a field study in which chronological necropsies were performed
[12]. Samples were tested to evaluate the humoral immune parameters schematized in Fig 1
and detailed further below.
Experimental study. Ninety seven 6 week-old pigs free from M. hyopneumoniae were
experimentally inoculated as described previously [4]. One uninfected group (Control; n = 6)
received sterile phosphate buffered saline (PBS). At 21 (n = 37) or 28 (n = 60) days post-inocu-
lation (dpi), all pigs were killed with an intravenous overdose of sodium pentobarbital and
subjected to necropsy examination. At that time (21 or 28 dpi), blood and broncho-alveolar
lavage fluid (BALF) samples were obtained and CVPC evaluation was assessed using the sys-
tem recommended by the European Pharmacopoeia (Ph. Eur., monograph number 04/
2013:2448). Sera were used for specific IgG, IgG1 and IgG2 detection, whereas IgG and IgA
antibodies were determined in BALF. Animal care and study procedures were conducted in
accordance with the guidelines of Good Experimental Practice, under the approval of the Ethi-
cal and Animal Welfare Committee of the Universitat Autònoma of Barcelona.
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Slaughterhouse study. A total of 54 batches of 54 different farms located in North-east-
ern, Central and South-eastern Spain, were included in the study [2]. A batch was defined as a
group of pigs (with a mean of 97 animals per batch) belonging to the same farm and sacrificed
on the same day at the slaughterhouse. From these 54 farms, 9 farms vaccinated pigs against
M. hyopneumoniae, 16 did not vaccinate and, from the remaining farms, no data was available
[2]. The pigs were killed in eight different slaughterhouses according to their own procedures.
Percentage of lungs affected by CVPC as well as mean lung lesion score per farm (sum of indi-
vidual scores/number of scored lungs) were assessed. In addition, blood samples from 20 ran-
domly selected pigs of each batch were taken before being sacrificed and IgG, IgG1 and IgG2
M. hyopneumoniae specific antibodies were determined from sera. Farms were then classified
as seropositive or seronegative according to the mean S/P ratio obtained from those 20 sam-
pled animals. In addition, mean farm IgG1 and IgG2 OD values were also obtained.
Chronological herd study. Fifty-eight pigs from a farrow-to-finish farm located in North-
eastern Spain with a history of EP associated respiratory problems were included in the analyses.
These piglets belonged to the control group (non-vaccinated) of a previously published work
[12]. Blood samples from these animals were taken at 1, 3, 6, 9, 12, 15, 18 and 22 weeks of age.
However, the initial number of pigs decreased over time because animals were randomly sacri-
ficed with an intravenous overdose of sodium pentobarbital, necropsied and CVPC evaluated
from 9 weeks of age (n = 10) onwards at 12 (n = 12), 15 (n = 7), 18 (n = 13) and 22 (n = 16)
weeks of age. Specific IgG antibodies were tested from all serum samples in each time point
whereas IgG1 and IgG2 specific isotypes were assessed only from sera obtained at the necropsy
time, from 9 to 22 weeks of age. Housing, husbandry and slaughtering conditions conformed to
the European Union Guidelines and Good Clinical Practices, under the approval of the Ethical
and Animal Welfare Committee of the Universitat Autònoma of Barcelona.
Pathological examination
In each of these studies, extension of gross lung lesions compatible with M. hyopneumoniae
infection (CVPC) was assessed using different scoring systems depending on the study. Thus,
in order to harmonize all lung lesion scores, those that were obtained through Madec and
Kobisch (1982) [13] (slaughterhouse study) and Hannan et al. (1982) [14] (chronological
Fig 1. Parameters and samples evaluated within the experimental, slaughterhouse and chronological herd studies. Macroscopic lung
lesions were quantified by the European Pharmacopoeia (Ph. Eur., monograph number 04/2013:2448) lung scoring system. All humoral immune
parameters were assessed by ELISA technique.
https://doi.org/10.1371/journal.pone.0175034.g001
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study) methodologies were converted to reference European Pharmacopoeia (Ph. Eur., mono-
graph number 04/2013:2448) scores by means of the equivalence formulae recently provided
[4].
M. hyopneumoniae IgG antibody detection
Sera derived from all the studies were tested for M. hyopneumoniae IgG antibodies by means
of a commercial indirect ELISA (Mycoplasma hyopneumoniae Antibody Test Kit; BioChek,
UK) and according to the manufacturer’s instructions. The relative amounts of specific IgG
antibodies in samples were expressed as sample-to-positive (S/P) ratio based on optical densi-
ties (OD) as follows: S/P = OD sample-OD mean negative control/ OD mean positive control-
OD mean negative control. Samples with an S/P of0.5 were considered positive whereas
samples with an S/P of<0.5 were considered negative. An S/P = 0 was given to those samples
with OD values below the mean OD of the negative control.
M. hyopneumoniae IgG antibody subtype detection
M. hyopneumoniae-specific IgG1 and IgG2 subtypes from sera were measured by using a mod-
ification of the above mentioned ELISA (Mycoplasma hyopneumoniae Antibody Test Kit; Bio-
Chek, UK). Mouse anti-pig IgG1 and IgG2 monoclonal antibodies (Bio-Rad Laboratories,
USA) were firstly tested in M. hyopneumoniae positive and negative sera diluted 1:30, 1:50,
1:70, 1:90, 1:120 and 1:150 with the sample diluent provided by the kit. As a result, 1:50 dilu-
tion (applied for total IgG antibodies determination according to manufacturer’s instructions)
was appropriate to discriminate between M. hyopneumoniae seropositive and seronegative
samples. After 30 min incubation, plates were washed and IgG1 and IgG2 antibodies diluted to
1:1000 were added. After incubating for 45 min, plates were washed again and alkaline phos-
phatase-labeled goat anti-mouse IgG polyclonal antibody (Bio-Rad Laboratories, USA) diluted
to 1:1000 was added to each plate well. After incubating for 45 min, plates were washed and
the reaction was visualized after 15 min incubation with the kit substrate reagent. Sample
absorbance was obtained by reading at 405 nm and results expressed as OD values. For each
plate, sample results were adjusted by subtracting the OD of the mean negative control pro-
vided by the kit. Furthermore, the cut-off was calculated as mean OD value of negative control
plus three standard deviations (SD). The threshold was established at an OD value of 0.13 for
both IgG1 and IgG2 antibodies.Values higher than this cut-off were considered positive
whereas values below this cut-off were considered negative.
Mucosal respiratory M. hyopneumoniae IgG and IgA antibody detection
Undiluted and previously centrifuged BALF samples from the experimental study were tested
for specific IgG antibodies by means of the above mentioned assay (Mycoplasma hyopneumo-
niae Antibody Test Kit; BioChek, UK) and conforming to the manufacturer’s instructions but
for the initial dilution of the sample. For IgA antibody detection, an alkaline phosphatase-
labelled goat anti-porcine IgA polyclonal antibody (Bethyl Laboratories, USA) was used as
described previously [15]. Sample absorbance was obtained by reading at 405 nm and results
expressed as OD values after subtraction of the mean OD value of BALF from the negative
control animals. The cut-off was calculated as mean OD value of the negative control plus
three standard deviations (SD) for both IgG and IgA BALF antibodies and established at an
OD value of 0.34 and 0.29, respectively. Whereas values higher than this cut-off were consid-
ered positive, values below this cut-off were considered negative.
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Statistical analyses
Statistical analyses were performed using SPSS software, version 15.0 (SPSS Inc., Chicago, Illi-
nois, USA). The significance level (α) was set at p<0.05. Variables included in the statistical
analyses were classified as categorical (presence or absence of CVPC and positive or negative
S/P ratios and OD values for IgG1 and IgG2 in serum and for IgG and IgA in BALF) or contin-
uous (S/P ratio, and IgG1 and IgG2 OD values in sera and IgG and IgA OD values in BALF,
percentage of lungs showing CVPC and Ph. Eur. scores). A non-parametric test (Mann-Whit-
ney) was used to evaluate the effect of any categorical variable over the continuous ones.
Besides, in order to study putative associations among continuous variables, a linear regression
analysis was carried out. Contingency tables with the corresponding chi-square statistics were
performed among categorical variables.
Results
Experimental study
None of the control pigs showed CVPC. Among inoculated animals, local and systemic M.
hyopneumoniae humoral immune parameters, percentage of animals showing CVPC as well as
the mean lung lesion score of the animals sacrificed at 21 or 28 dpi are represented in Table 1.
Lung lesion evaluation. CVPC was observed both in pigs sacrificed at 21 and 28 dpi and
no significant differences (p>0.05) were found in terms of number of animals affected neither
in mean lung lesion scores (Table 1).
Serology. Number of seropositive animals was higher at 28 than at 21 dpi (p = 0.09)
(Table 1). Although below the positivity threshold, mean S/P ratio at 28 dpi was significantly
higher than at 21. While all seropositive pigs (n = 15) showed CVPC with different levels of
severity (from 0.4 to 32% of lung weight damaged), a total of 63 out of 82 seronegative animals
(76.8%) had CVPC. In addition, no significant (p>0.05) correlation was found between indi-
vidual lung lesion scores and S/P ratios. Nevertheless, the mean S/P ratio of animals with
CVPC (0.32±0.36) was significantly higher (p<0.05) than the one from animals without lung
lesions (0.03±0.05) at 28 dpi.
Serum IgG1 and IgG2 subclasses. Neither IgG1 nor IgG2 against M. hyopneumoniae
were detected in sera at 21 dpi, even in those three animals that seroconverted for total IgG
(Table 1). However, all the animals that seroconverted by 28 dpi (n = 12) were positive to both
isotypes. A significant positive correlation (r = 0.77, p<0.0001) between OD values of both
antibody subclasses was observed, but serum IgG2 amounts were found to be significantly
higher (p<0.05) than IgG1 ones at 28 dpi. Furthermore, significantly higher (p<0.05) IgG1
and IgG2 levels were detected in those animals showing CVPC in comparison with those
Table 1. Immunopathological data obtained from the experimental study. Number (%) of animals showing CVPC, mean Ph. Eur. Score (± SD),
mean S/P ratio (± SD) and number (%) of seropositive (IgG) and positive animals to M. hyopneumoniae-IgG1 and IgG2 in sera and to IgG and IgA
antibodies in BALF at 21 and 28 dpi. Different superscripts within a column indicate significant differences among days post-inoculation (p<0.05).
Lung pathology Serology Sera isotypes detection BALF antibodies detection
Days post-
inoculation (dpi)
No. of animals
with CVPC (%)
Mean Ph. Eur.
Score (± SD)
No. of seropositive
animals (%)
Mean S/P
ratio (± SD)
No. of IgG1
positive animals
(%)
No. of IgG2
positive animals
(%)
No. IgG positive
animals (%)
No. of IgA
positive animals
(%)
21 (n = 37) 30 (81.1)a 7.7 (± 8.1)a 3 (8.1)a 0.09 (±
0.22)a
0 (0)a 0 (0)a 34 (91.9)a 36 (97.3)a
28 (n = 60) 48 (80)a 9.5 (± 10.3)a 12 (20)a 0.26 (±
0.34)b
18 (30)b 32 (53)b 37 (61.7)b 45 (75)b
https://doi.org/10.1371/journal.pone.0175034.t001
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without lung lesions (Fig 2). However, no association between IgG1 or IgG2 OD values and
lung lesion scores at individual animal level was observed.
Local humoral immune response. Number of positive animals for BALF IgG and IgA
antibodies was significantly higher (p<0.05) at 21 dpi than at 28 dpi (Table 1). A significant
increase (p<0.05) of both specific IgG and IgA antibodies in BALF was observed in those ani-
mals showing CVPC in comparison with those without lung lesions (Fig 3A and 3B, respec-
tively), but for specific IgG BALF antibodies at 21 dpi (p = 0.07) (Fig 3A). Although moderate
to low, a significant positive correlation (r = 0.49, p<0.05) between IgG BALF OD values and
lung lesion scores at individual level was observed. Nonetheless, this relationship was not
observed with regard to IgA BALF OD values.
Slaughterhouse study
Gross pathology and serology. All the 54 farms included in the present study were found
to be affected by CVPC. Globally, mean percentage of lungs affected by CVPC and mean lung
lesion score (Ph. Eur.) were 68.1 (min 34, max 99) and 5.15 (min 0.19, max 16.38), respectively.
Based on the results obtained from the 20 randomly tested serum samples per farm, 40
(74.1%) farms were considered seropositive and the remaining 14 (25.9%) seronegative. Addi-
tionally, seropositive farms had a significantly higher (p<0.001) mean lung lesion score as well
as percentage of lungs affected by CVPC than seronegative ones (Table 2). However, no signif-
icant relationship (p>0.05) was found between the mean S/P value of the 20 randomly col-
lected sera and the mean lung lesion score at individual farm level.
Serum IgG1 and IgG2 subclasses. All the 40 farms classified as seropositive showed posi-
tive IgG2 humoral immune responses and 24 of them (60%) had also IgG1 positive reactions.
Similarly to what was observed at experimental level, a significant positive correlation
Fig 2. Mean IgG1 and IgG2 isotypes OD values (±SD) in animals with and without CVPC at 28 dpi from
the experimental study. Different superscripts indicate significant differences of IgG1 and IgG2 antibody
levels among animals with and without CVPC (p<0.05). Discontinuous line represents the positivity threshold.
https://doi.org/10.1371/journal.pone.0175034.g002
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Fig 3. Mean M. hyopneumoniae IgG (A) and IgA (B) OD values (±SD) in BALF samples from animals of
the experimental study with and without CVPC at 21 and 28 dpi. Different superscripts indicate significant
differences of antibody levels among animals with and without CVPC at 21 and 28 dpi (p<0.05). Discontinuous
line represents the positivity threshold.
https://doi.org/10.1371/journal.pone.0175034.g003
Table 2. Mean Ph. Eur. Score (±SD) and percentage of affected lungs by CVPC (±SD) in seropositive and seronegative farms from the slaughter-
house study. Different superscripts within a row indicate significant differences among types of farms (p<0.05).
Seropositive Farms Seronegative Farms
Mean Ph. Eur. Score (±SD) 6.09 (± 3.89)a 2.47 (± 1.91)b
Mean percentage of affected lungs (±SD) 71.73 (± 12.78)a 57.57 (± 12.07)b
https://doi.org/10.1371/journal.pone.0175034.t002
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(r = 0.59, p<0.0001) between both isotypes was detected and IgG2 response against M. hyop-
neumoniae was found to be significantly (p<0.0001) higher than the IgG1 one. Indeed, a sig-
nificant positive correlation was found between S/P ratios and IgG2 OD values (r = 0.83,
p<0.0001) whereas such relationship was not as good when considering IgG1 OD values
(r = 0.48, p = 0.0002). Though, no significant association (p>0.05) between the mean IgG2 OD
value and the mean lung lesion score at individual farm level was found.
Chronological herd study
Gross pathology and serology. M. hyopneumoniae serological results from all monitored
pigs and pathological results obtained along sequential necropsies are summarized in Table 3.
From 1 to 12 weeks of age, the percentage of seropositive pigs was below 10%. However, from
15 weeks of age onwards, percentage of seropositive pigs increased progressively towards the
end of the finishing period. Animals with CVPC began to appear from 12 weeks of age onwards.
By the end of the study (22 weeks), the highest percentage of seropositive animals paralleled
with the highest mean S/P values. Although not statistically significant (p>0.05), seropositive
animals necropsied at 15, 18 and 22 weeks of age had higher lung lesion scores in comparison
with the seronegative counterparts. Nonetheless, a statistical tendency between individual S/P
ratios and lung lesion scores was observed at 22 weeks of age (r = 0.49, p = 0.056).
Serum IgG1 and IgG2 subclasses. Following the seroconversion pattern, mean M. hyop-
neumoniae IgG2 levels increased progressively from 15 weeks of age until the end of the study
(22 weeks), when the mean maximum IgG2 levels in sera were reached (Fig 4). On the contrary,
IgG1 mean levels maintained below the positivity threshold along the studied period but at 9
weeks of age. Indeed, mean IgG2 serum levels were significantly higher (p<0.05) than IgG1
ones at both 18 and 22 weeks of age. Additionally, a positive significant correlation was found
between S/P ratios and IgG2 OD values in 18 (r = 0.83, p = 0.0004,) and 22 (r = 0.66, p = 0.006)
week-old pigs. Notwithstanding, individual IgG2 OD values were positively correlated with
mean lung lesion scores in 12 (r = 0.81, p = 0.001), 15 (r = 0.83, p = 0.04), 18 (r = 0.71, p = 0.063)
and 22 (r = 0.62, p = 0.01) week-old animals.
Discussion
This study was motivated by the interest to identify an easy ante-mortem parameter that would
be used to reliably forecast the prevalence and severity of CVPC during the life of the pig.
While serology (particularly useful for economical, rapid and high-throughput sample analy-
sis) is the most common monitoring tool used to determine the M. hyopneumoniae status of a
Table 3. M. hyopneumoniae serological results from all pigs at all time points and pathological results obtained along sequential necropsies from
the chronological herd study. Different superscripts within a row indicate significant differences between weeks of age (p<0.05). NA, non-available.
Weeks of age
1 3 6 9 12 15 18 22
No. of animals tested (n) 58 58 58 58 48 36 29 16
No. of seropositive animals
(%)
5 (8.6)a 3 (5.2)a 2 (3.4)a 3 (5.2)a 2 (4.2)a 6 (16.7)b 15 (51.7)c 11 (68.8)c
Mean S/P (±SD) 0.18 ±
(0.59)a
0.06 ±
(0.18)a
0.07 ±
(0.23)a
0.08 ±
(0.18)a
0.11 ±
(0.36)a
0.33 ±
(0.65)b
1.01 ±
(1.35)c
1.46 ±
(1.32)c
No. of necropsied animals (n) NA NA NA 10 12 7 13 16
No. of animals with CVPC (%) NA NA NA 0 (0)a 4 (33.3)b 6 (85.7)c 8 (61.5)b, c 13 (81.3)c
Mean Ph. Eur. Score (±SD) NA NA NA 0,00 ±
(0,00)a
1.35 ±
(2.35)b
3.32 ±
(2.57)b
3.09 ±
(7.63)c
6.94 ±
(8.53)c
https://doi.org/10.1371/journal.pone.0175034.t003
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pig population [3], several studies have reported a positive association between serum antibody
levels against M. hyopneumoniae and CVPC [2, 7–10]. On that basis, this work further studied
the value of the humoral immune response to M. hyopneumoniae as a CVPC estimator by describ-
ing the association between different specific antibody isotype responses, both at local and sys-
temic levels, and CVPC. Such putative relationship was evaluated in three different scenarios.
First, experimental conditions allow modelling the acute phase of M. hyopneumoniae infection.
Second, the relevance of CVPC is commonly assessed in slaughter-aged pigs [1, 2, 6], although no
information about the M. hyopneumoniae infectious status is known. Lastly, pigs chronologically
necropsied enabled the assessment of such relationship at different time points along M. hyopneu-
moniae infection dynamics. Despite CVP is frequently attributed to M. hyopneumoniae infection
[1, 2, 7], it might be caused by other microorganisms (e.g. Pasteurella multocida and swine influ-
enza virus) as well as influenced by farm management and housing conditions [1, 2, 7, 12, 16].
Although the present results confirm the presence of M. hyopneumoniae circulation in herds from
both the slaughterhouse and chronological studies [2, 12], it should be considered that the afore-
said factors may have influenced CVPC and, in turn, the reliability of the association with the
humoral immune response to M. hyopneumoniae.
At the experimental level, the local humoral immune response was stronger than the sys-
temic one after three weeks of inoculation. Inversely, once the systemic humoral immune
response began to increase by 28 dpi, revealed by a higher number of seropositive animals and
increased IgG1 and IgG2 responses, a decline of both IgG and IgA antibody levels in BALF
was observed. In the present work, higher levels of specific IgG and IgA mucosal antibodies
were detected in those animals with CVPC in comparison with those without lung lesions. In
agreement, there is a remarkable increase in the number of cells producing immunoglobulins
Fig 4. Mean S/P ratios and mean IgG1 and IgG2 OD values in sera from pigs sequentially necropsied in the
chronological herd study. *Significant differences among mean IgG1 and IgG2 OD values (p<0.05).
https://doi.org/10.1371/journal.pone.0175034.g004
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A and G in the lungs of M. hyopneumoniae experimentally infected pigs [17–19]. Additionally,
the number of cells producing specific IgG appeared to be notably higher than the ones pro-
ducing IgA at lymphoid and lung tissue levels [19]. Actually, although with low to moderate
correlation, specific IgG antibody amounts in BALF were found to be the best parameter to
foresee CVPC at the level of the individual pig. While IgA antibodies associate with the muco-
sal layer in the nasal cavity, trachea and bronchi and would block M. hyopneumoniae attach-
ment to epithelial cells, IgG antibodies are mainly found in the alveoli, being more active at
lung parenchyma level through participation in opsonization and phagocytosis [20, 21]. There-
fore, differential location of IgG and IgA in the respiratory tract might explain why BALF IgG
levels were better correlated with CVPC scores. Similarly to earlier results [22], the present
findings from experimentally inoculated pigs confirm that the humoral respiratory immune
response against M. hyopneumoniae develops faster than the systemic one, which is commonly
delayed in onset but persists longer. Henceforth, in an early stage of M. hyopneumoniae infec-
tion, a mucosal-based antibody measurement (such in BALF and tracheobronchial lavage sam-
ples) would be probably better as a CVPC predictor than a serological-based one.
While the local humoral immune response could play a major role in the pathogenesis of
M. hyopneumoniae acute infection, IgG at the systemic level may be more important in later
phases. As supporting evidence of this notion, a relationship between pneumonic lesions and
IgG serum levels against Mycoplasma pulmonis in mice has been indicated [23]. Noticeable,
reduced production of IgG was one of the most prominent characteristics in the immunologi-
cal function of a mycoplasmal pneumonia resistance Landrace line [24]. Results obtained from
slaughtered and chronologically necropsied pigs suggest that the amount of M. hyopneumoniae
specific IgG might be related with the severity of CVPC and that could help to forecast preva-
lence and severity of EP-like lung lesions using a population based approach. However, the S/P
value was not a good measure to predict severity of CVPC at an individual animal or farm
level. Unfortunately, the specific relationship between serological responses and lung lesion
scores in the 20 sampled slaughtered animals per farm was not possible. Thus, the association
between both parameters at an individual slaughter weight animal level could not be assessed.
Lung lesions progress and regress throughout the lives of the pigs [6, 25, 26]. While pigs can
show recovering lung lesions 8 to 12 weeks after M. hyopneumoniae exposure [27, 28], serum
specific antibodies persist for longer periods [29, 30]. In fact, CVPC severity may depend on
the time elapsed from M. hyopneumoniae seroconversion to the slaughter [26, 27, 31]. Thus,
the main limitations to describe CVPC prevalence and severity in slaughtered pigs are due to
the fact that CVPC consequence of early M. hyopneumoniae infections would probably escape
detection, whereas animals infected close to the slaughter date might show CVPC but no sero-
conversion. For a better understanding of the humoral immunity value to forecast lifetime
CVPC, samples from pigs that were followed up from birth to 22 weeks of age with sequential
necropsies were evaluated. In such scenario, CVPC appeared earlier (at 12 weeks of age) than
evident seroconversion (15 weeks of age) and both the percentage of seropositive pigs and ani-
mals with lung lesions increased progressively towards the end of the finishing period. Hence-
forth and similar to what was seen in slaughtered pigs, seropositivity was linked with more
severe CVPC, but no significant correlation was observed between individual S/P ratios and
lung lesion scores at any time point. While the chronological study was performed in non-vac-
cinated pigs, slaughtered animals belonged to batches from vaccinated and non-vaccinated
herds. Although CVPC in slaughtered pigs was not importantly affected by M. hyopneumoniae
vaccination [2], we cannot completely rule out that vaccination could affect the association
pattern between serology and CVPC.
A novel approach aimed to determine whether there was a measurable difference in IgG1
and/or IgG2 subclasses in pig sera with and without CVPC was raised. Predominance of one
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IgG subclass over another in an immune response suggests Th1/Th2 bias [32]. Dominant
secretion of IgG1 antibodies conveys differentiation of naïve Th cells into Th2, which are
involved mainly in the activation of the humoral part of the immune response. In contrast,
major detection of IgG2 is related to Th1 cells activation, which preferentially promotes the
cellular immune response [32, 33]. The relevant immune response type and IgG subclass dis-
tribution could be critical for protection against a particular disease [34]. However, the
involvement of IgGl and IgG2 subclass responses to M. hyopneumoniae infection and the ratio
of these subclasses with respect to protection are not yet known. In the murine respiratory
mycoplasma infection model, specific Th2 cell responses were found to be involved in the
development of inflammatory lung lesions. In contrast, the ability to generate a Th1 cell-medi-
ated lung immune response was related with more protection [35]. Remarkably, while this
functional polarization of the Th cells has been extensively studied in mice and humans, in
pigs it is less defined [33].
In the present study, the systemic humoral immune response in both experimental and nat-
ural M. hyopneumoniae infections was predominate the IgG2 subclass. In fact, IgG2 OD values
and S/P values (total IgG) were found to be significantly and positively correlated. Moreover,
the chronological study revealed that this antibody subclass level developed in parallel with the
specific IgG response, indicating that IgG2 might probably be the main component of the sys-
temic humoral immune response against M. hyopneumoniae. Contrarily, previous studies have
reported a higher IgG1 than IgG2 antibody response in pigs challenged with M. hyopneumo-
niae at local [36, 37] and systemic [36] levels. Although reasons for such inconsistencies are
unknown, while in such previous studies IgG1 and IgG2 subclasses against P46 [37] or P97
[36] proteins were detected, in the present case, detected antibodies were directed to a recom-
binant M. hyopneumoniae antigen. The latter might have had a certain influence on the
observed IgG isotype bias, as it has been demonstrated that the antigen may determine the
type of immune response that develops [33]. Notwithstanding, IgG2 OD values were found to
be better estimators of lifetime pneumonia than S/P values. Indeed, the IgG2 OD value was the
humoral immune parameter that better correlated with the lung lesion score. Despite the fact
that a Th1 shifted immune response has been described in a mycoplasmal pneumonia resistant
Landrace genetic line [24], present results suggest the absence of a protective role of IgG2 sub-
class against M. hyopneumoniae. Interestingly, Th1 immune response is required for host
defense against intracellular pathogens [20, 33]. Although M. hyopneumoniae is regarded as an
extracellular bacteria [38], it has been recently speculated as an intracellular pathogen [39].
Altogether, the present finding of IgG isotype bias as a correlate of M. hyopneumoniae associ-
ated lung lesions may provide an incentive for further evaluation of the Th immune response
in M. hyopneumoniae infection scenarios.
Conclusions
The present study provides insight into those potential mechanisms of immunity that might
be implicated in the pathogenesis of M. hyopneumoniae infection in pigs. To our knowledge,
this is the first study examining the involvement of different M. hyopneumoniae specific anti-
body isotype responses in lung lesion development. The results indicated an increased anti-
body-specific production that most likely is associated to lung lesion severity during infection.
Since M. hyopneumoniae systemic humoral immune response is delayed in onset, a mucosal-
based antibody measurement would be preferably chosen to predict lung lesion severity at
early stages of infection. Being M. hyopneumoniae monitoring by ELISA one of the most com-
mon practices on swine farms, the obtained results may give an indication of the lung lesion
severity in a certain batch. In addition, there was a clear trend towards the IgG2 response,
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which may reflect a dominant Th1-controlled antibody-mediated immune response. However,
the measurement of other parameters related with the cellular immune response would be
required to further study the role that the Th1/Th2 bias could have in M. hyopneumoniae
infections.
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